THE ALAN MOREMENT MEMORIAL FUND
AMMF is dedicated to raising the awareness of cholangiocarcinoma (bile duct cancer), supplying information to those who need it, and raising funds to support specialised research teams in their work into the causes, methods of earlier diagnosis and treatments of this disease.
Objects
THE TRUSTEES SHALL HOLD THE TRUST FUND AND ITS INCOME UPON TRUST FOR THE FOLLOWING OBJECTS (“THE OBJECTS”):FOR THE PUBLIC BENEFIT, THE ADVANCEMENT OF HEALTH, INCLUDING BY RAISING THE AWARENESS AND UNDERSTANDING OF CHOLANGIOCARCINOMA (BILE DUCT CANCER) AND RELATED CANCERS AND CONDITIONS INCLUDING THROUGH THE:PROMOTION OF RESEARCH INTO CAUSES, TREATMENTS AND CURES; ANDDISSEMINATION OF INFORMATION TO PATIENTS, CARERS AND HEALTH CARE PROFESSIONALS.
Latest income
£0
Latest spending
£0
Registered
2002
Policies the charity declares
- Complaints handling
- Safeguarding vulnerable beneficiaries
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/01/2023
- Volunteers: 3
Self-declared on the annual return for the financial year ending 31/01/2022
- Volunteers: 3
Structured financials (annual return, FY ending 31/01/2022)
Total income
£836k
Total spending
£630k
Cost of raising funds
£2k
Reserves (reported)
£681k
Employees
3
Trustees
- Noel Corrigan FORSchair
- Gillian Corrigan
- HARRY CORRIGAN
- TOM MOREMENT
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/01/2026 | £0 | £0 |
| 31/01/2025 | £0 | £0 |
| 31/01/2024 | £0 | £0 |
| 31/01/2023 | £132k | £255k |
| 31/01/2022 | £836k | £630k |